Type : Contract
MALDI REPAIR Solicitation ID/Procurement Identifier: 36C26023P0213 Ultimate Completion Date: Fri Mar 31 17:00:00 GMT 2023
MALDI REPAIR Solicitation ID/Procurement Identifier: 36C26023P0213 Ultimate Completion Date: Fri Mar 31 17:00:00 GMT 2023
PREVENTATIVE AND CORRECTIVE/REMEDIAL MAINTENANCE REPAIR SERVICE AGREEMENT: BRUKER BIOTYPER MALDI MASS SPECTROMETER (SERIAL NUMBER: 185366505210) Solicitation ID/Procurement Identifier: FDA-SOL-1225491 Ultimate Completion Date: Mon Sep 15 17:00:00 GMT 2025
Food and Drug Administration (FDA), is conducting market research to support the Center for Biologics Evaluation and Research (CBER), requires preventative maintenance, corrective/remedial maintenance repair service agreement on a Bruker Biotyper MALDI mass spectrometer.
The FDA/CBER/ requires preventative maintenance, corrective/remedial maintenance repair service agreement on a Bruker Biotyper MALDI mass spectrometer (Serial Number: 185366505210) [JJ1] to maintain the functionality of the equipment for ongoing, vital experiments progressing. This instrument is used for high throughput bacterial identification from a single colony which is required for several projects in the lab.
; Repair serviceShipping of spare parts for the repairs will take ten (10) calendar days of the date of award.
EPA¿s Office of Research and Development, National Health and Environmental Effects Research Laboratory (ORD/NHEERL) is equipped with a 4800 Maldi TOF/TOF Analyzer. The instrument repair cost was partly covered by the original manufacturer AB Sciex under a limited-service contract plan which provides parts, labor and travel for remedial repairs and a guaranteed 3 business day onsite response time.
Food and Drug Administration (FDA), Office of Acquisitions and Grant Services intends to award a sole source, firm fixed-price contract to Bruker BioSpin Corporation for Preventative Maintenance & Repair Services Bruker MALDI TOF Mass Spectrometer. The anticipated period of performance for this procurement is a 12-month base and four options period.